Long-term suppression of recurrent herpes labialis by low-dose oral acyclovir in an immunocompromised patient.
A patient with chronic lymphocytic leukemia and severe and frequently recurring herpes labialis received oral acyclovir for more than 18 months, during most of this period at a low dosage (400 mg/d). This regimen was fully successful in preventing recurrences, with no adverse effects.
D000212:Acyclovir / Q000008:administration & dosage*; D000284:Administration, Oral; D000368:Aged; D006560:Herpes Labialis / Q000188:drug therapy*; D006801:Humans; D007108:Immune Tolerance; D007945:Leukemia, Lymphoid / Q000150:complications; D008134:Long-Term Care; D008297:Male; D012008:Recurrence
D000212:Acyclovir